سعر تاروليمس مرهم 03% 15 جم 0.03% 2025

Tacrolimus 0.03% ointment for topical use (Andalous Pharma), a topical calcineurin inhibitor; 15 g tube.

• Second-line, short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised patients who failed or cannot use other topical prescription treatments (0.03% for adults and children 2-15 years).DailyMed (U.S. National Library of Medicine)

• Most common: skin burning and pruritus at the application site; varicella zoster and vesiculobullous rash were more frequent than vehicle in children on 0.03%.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• History of hypersensitivity to tacrolimus or any component of the ointment.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Long-term safety of topical calcineurin inhibitors is not established; rare malignancies (skin, lymphoma) have been reported; avoid continuous long-term use and limit application to affected areas.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Minimise or avoid natural or artificial sunlight exposure during treatment; not studied in immunocompromised patients.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• No adequate well-controlled studies of topical tacrolimus in pregnant women; experience too limited to assess safety.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Tacrolimus is excreted in human milk; decide whether to discontinue nursing or the drug.International label, same formulation · DailyMed (U.S. National Library of Medicine)